The company is being acquired by KKR and Walgreens Boots Alliance.
News & Analysis: PharMerica
Rumors that the company may be exploring a sale sparked investor enthusiasm.
Despite a mixed jobs report the S&P 500 trudges higher, while Intercept Pharmaceuticals, Endocyte, and PharMerica soar by at least 27%!
PharMerica issues its preliminary 2014 guidance and investors cheer. Is there still room for shares to move higher or should investors head for the exits?
Endo Health, PharMerica, and Almost Family stood among the biggest winners this week in health-care -- but Keryx wasn't far behind.
Drug distributor Omnicare provides investors with stable growth as aging boomers demand more treatment and drug manufacturers focus more on higher margin specialty drugs.
Is this meaningful? Or just another movement?
Don't just count the cash, time it.
PharMerica stock plunges after the loss of the company's biggest customer.
PharMerica delivers the perfect prescription to shareholders in its first-quarter earnings report.